124 related articles for article (PubMed ID: 38691085)
21. Identification of Clinical and Laboratory Parameters Associated with the Development of Acute Chest Syndrome during Vaso-Occlusive Episodes in Children with Sickle Cell Disease: A Preliminary Step before Assessing Specific and Early Treatment Strategies.
Madhi F; Kamdem A; Jung C; Carlier-Gonod A; Biscardi S; Busca J; Arnaud C; Hau I; Narbey D; Epaud R; Pondarre C
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683997
[TBL] [Abstract][Full Text] [Related]
22. Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell disease.
Karkoska K; Appiah-Kubi A; Rocker J; Stoffels G; Aygun B
Br J Haematol; 2019 Sep; 186(6):855-860. PubMed ID: 31148158
[TBL] [Abstract][Full Text] [Related]
23. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery.
Forrest JB; Camu F; Greer IA; Kehlet H; Abdalla M; Bonnet F; Ebrahim S; Escolar G; Jage J; Pocock S; Velo G; Langman MJ; Bianchi PG; Samama MM; Heitlinger E;
Br J Anaesth; 2002 Feb; 88(2):227-33. PubMed ID: 11883386
[TBL] [Abstract][Full Text] [Related]
24. Comparison between ketorolac- and fentanyl-based patient-controlled analgesia for acute kidney injury after robot-assisted radical prostatectomy: a retrospective propensity score-matched analysis.
Kim DH; Jeon YT; Kim HG; Oh AY; Ryu JH; Bae YK; Koo CH
World J Urol; 2023 May; 41(5):1437-1444. PubMed ID: 37004573
[TBL] [Abstract][Full Text] [Related]
25. Does ketorolac administration at the time of hypospadias surgery increase unplanned encounters in the immediate postoperative period?
Mittal S; Eftekharzadeh S; Weinstein C; Fombona A; Hyacinthe N; Shah YB; Weiss DA; Kolon TF; Shukla AR; Canning DA; Srinivasan AK; Zaontz MR; Long CJ
J Pediatr Urol; 2023 Jun; 19(3):289.e1-289.e6. PubMed ID: 36774243
[TBL] [Abstract][Full Text] [Related]
26. Modulation of pain in pediatric sickle cell disease: understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation.
Smith TP; Schlenz AM; Schatz JC; Maitra R; Sweitzer SM
Blood Cells Mol Dis; 2015 Feb; 54(2):155-9. PubMed ID: 25486928
[TBL] [Abstract][Full Text] [Related]
27. Use of ketorolac in sickle-cell disease and vaso-occlusive crisis.
Goodman E
Lancet; 1991 Sep; 338(8767):641-2. PubMed ID: 1679183
[No Abstract] [Full Text] [Related]
28. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
[TBL] [Abstract][Full Text] [Related]
29. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
[TBL] [Abstract][Full Text] [Related]
30. Sensitization to acute procedural pain in pediatric sickle cell disease: modulation by painful vaso-occlusive episodes, age, and endothelin-1.
Schlenz AM; McClellan CB; Mark TR; McKelvy AD; Puffer E; Roberts CW; Sweitzer SM; Schatz JC
J Pain; 2012 Jul; 13(7):656-65. PubMed ID: 22633685
[TBL] [Abstract][Full Text] [Related]
31. Comparing two doses of intramuscular ketorolac for treatment of acute musculoskeletal pain in a military emergency department.
Turner NJ; Long DA; Bongiorno JR; Katoski TP; Jin LM; Horsch JP; Ahern BJ
Am J Emerg Med; 2021 Dec; 50():142-147. PubMed ID: 34365063
[TBL] [Abstract][Full Text] [Related]
32. Intramuscular Fentanyl and Ketorolac Associated with Superior Pain Control After Pediatric Bilateral Myringotomy and Tube Placement Surgery: A Retrospective Cohort Study.
Stricker PA; Muhly WT; Jantzen EC; Li Y; Jawad AF; Long AS; Polansky M; Cook-Sather SD
Anesth Analg; 2017 Jan; 124(1):245-253. PubMed ID: 27861435
[TBL] [Abstract][Full Text] [Related]
33. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain.
Carden MA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown K; Casper TC; Chapman LL; Chumpitazi CE; Cohen D; Dampier C; Ellison AM; Grasemann H; Hickey RW; Hsu LL; Leibovich S; Powell E; Richards R; Sarnaik S; Weiner DL; Morris CR;
Am J Hematol; 2019 Jun; 94(6):689-696. PubMed ID: 30916794
[TBL] [Abstract][Full Text] [Related]
34. Opioid prescription practices at discharge and 30-day returns in children with sickle cell disease and pain.
Okorji LM; Muntz DS; Liem RI
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27800652
[TBL] [Abstract][Full Text] [Related]
35. Concomitant tacrolimus and ketorolac therapy in pediatric liver transplant recipients: Teaching old dogma new tricks.
Chen J; Salerno D; Breslin N; Chowdhury T; Lobritto S; Martinez M; Goldner D; Vittorio J
Clin Transplant; 2021 Jan; 35(1):e14141. PubMed ID: 33145821
[TBL] [Abstract][Full Text] [Related]
36. Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension.
Audard V; Homs S; Habibi A; Galacteros F; Bartolucci P; Godeau B; Renaud B; Levy Y; Grimbert P; Lang P; Brun-Buisson C; Brochard L; Schortgen F; Maitre B; Mekontso Dessap A
Nephrol Dial Transplant; 2010 Aug; 25(8):2524-9. PubMed ID: 20179008
[TBL] [Abstract][Full Text] [Related]
37. Pain management in children and adolescents with sickle cell disease.
Jerrell JM; Tripathi A; Stallworth JR
Am J Hematol; 2011 Jan; 86(1):82-4. PubMed ID: 20949441
[TBL] [Abstract][Full Text] [Related]
38. Intravenous fluid therapy and hospital outcomes for vaso-occlusive episodes in children, adolescents, and young adults with sickle cell disease.
Haimed A; Weiss R; Kwon S; Bhat R; Badawy SM
Pediatr Blood Cancer; 2024 Feb; 71(2):e30781. PubMed ID: 38015105
[TBL] [Abstract][Full Text] [Related]
39. Identification of Risk Factors for Acute Kidney Injury from Intravenous Ketorolac in Geriatric Trauma Patients.
Hall ST; Mangram AJ; Barletta JF
World J Surg; 2022 Jan; 46(1):98-103. PubMed ID: 34553259
[TBL] [Abstract][Full Text] [Related]
40. Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes.
Jacob E; Mueller BU
Pain Med; 2008; 9(1):13-21. PubMed ID: 18254762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
